Fig. 1

a Comparison of late gadolinium enhancement (LGE) involvement and extracellular volume fraction (ECV) between pathogenic or likely pathogenic sarcomere gene mutation (SM) group and non-SM group in all segments. b Comparison of global and septal ECV between SM group and non-SM group in segments without LGE